Immune Phenomena in Myeloid Neoplasms: An “Egg or Chicken” Question
Open Access
- 29 September 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12, 751630
Abstract
Immune phenomena are increasingly reported in myeloid neoplasms, and include autoimmune cytopenias/diseases and immunodeficiency, either preceding or complicating acute myeloid leukemia, myelodysplastic syndromes (MDS), chronic myeloproliferative neoplasms, and bone marrow failure (BMF) syndromes. Autoimmunity and immunodeficiency are the two faces of a dysregulated immune tolerance and surveillance and may result, along with contributing environmental and genetic factors, in an increased incidence of both tumors and infections. The latter may fuel both autoimmunity and immune activation, triggering a vicious circle among infections, tumors and autoimmune phenomena. Additionally, alterations of the microbiota and of mesenchymal stem cells (MSCs) pinpoint to the importance of a permissive or hostile microenvironment for tumor growth. Finally, several therapies of myeloid neoplasms are aimed at increasing host immunity against the tumor, but at the price of increased autoimmune phenomena. In this review we will examine the epidemiological association of myeloid neoplasms with autoimmune diseases and immunodeficiencies, and the pivotal role of autoimmunity in the pathogenesis of MDS and BMF syndromes, including the paroxysmal nocturnal hemoglobinuria conundrum. Furthermore, we will briefly examine autoimmune complications following therapy of myeloid neoplasms, as well as the role of MSCs and microbiota in these settings.Keywords
This publication has 80 references indexed in Scilit:
- Somatic Mutations and Clonal Hematopoiesis in Aplastic AnemiaNew England Journal of Medicine, 2015
- Regulation of lung immunity and host defense by the intestinal microbiotaFrontiers in Microbiology, 2015
- Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective studyRheumatology, 2015
- Successful Management of Chronic Refractory Immune Thrombocytopenia with Laparoscopic Splenectomy in a Patient with Acute Promyelocytic LeukemiaIndian Journal of Hematology and Blood Transfusion, 2012
- Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDSLeukemia Research, 2011
- Clinical Effect of Point Mutations in Myelodysplastic SyndromesNew England Journal of Medicine, 2011
- Disappearing Myelodysplastic Syndrome-Associated Hemolytic Anemia in Leukemic TransformationInternational Archives of Allergy and Immunology, 2010
- Nature and functions of autoantibodiesNature Clinical Practice Rheumatology, 2008
- The immune system: our mobile brain?Immunology Today, 1985
- Coombsʼ Positive Hemolytic Anemia in Myelofibrosis with Myeloid MetaplasiaThe American Journal of the Medical Sciences, 1969